TGF-β Signalling Mediates the Anti-Inflammatory Activity of Enamel Matrix Derivative In Vitro

Area of Science:

• Periodontal tissue regeneration
• Cellular and molecular biology
• Immunology

Background:

• Enamel matrix derivative (EMD) promotes periodontal tissue regrowth.
• EMD exhibits anti-inflammatory properties and TGF-β activity in vitro.
• The mechanism by which EMD's anti-inflammatory effects are mediated by TGF-β remains unclear.

Purpose of the Study:

• To investigate whether TGF-β activity mediates the anti-inflammatory effects of EMD.
• To establish a bioassay for confirming EMD's anti-inflammatory activity.
• To elucidate the role of TGF-β signaling in EMD-induced anti-inflammation.

Main Methods:

• Established a bioassay using RAW 264.7 macrophage cell line and primary macrophages.
• Confirmed TGF-β1 presence in EMD via immunoassay and Smad2/3 translocation.
• Utilized SB431542, a TGF-β receptor type I kinase inhibitor, to block signaling pathways.
• Assessed IL-6, CXCL2, IL-1β, and TNF-α expression in stimulated cells.

Main Results:

• EMD significantly reduced IL-6 expression in macrophages.
• TGF-β1 was confirmed in EMD, inducing Smad2/3 nuclear translocation.
• SB431542 reversed the anti-inflammatory activity of EMD and TGF-β in LPS-stimulated macrophages.
• SB431542 also reversed EMD's anti-inflammatory effects in IL-1β and TNF-α-stimulated ST2 cells.

Conclusions:

• TGF-β activity mediates at least part of the anti-inflammatory activity of Enamel Matrix Derivative (EMD) in vitro.
• This finding clarifies the mechanism underlying EMD's therapeutic potential in periodontal regeneration.
• Targeting TGF-β signaling could enhance EMD's efficacy in regenerative medicine.